The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience

Lignende værker

• Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma
  af: Krajewska, Jolanta, et al.
  Udgivet: (2019)
• Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi
  af: Kukulska Aleksandra, et al.
  Udgivet: (2010-11-01)
• Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi
  af: Kukulska, Aleksandra, et al.
  Udgivet: (2010)
• 13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study
  af: Handkiewicz-Junak, Daria, et al.
  Udgivet: (2009)
• TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma
  af: Rusinek, Dagmara, et al.
  Udgivet: (2020)